Ten years of experience with the pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine (<i>Synflorix</i>) in children.

Lecrenier, Nicolas; Marijam, Alen; Olbrecht, Jan; Soumahoro, Lamine; Nieto Guevara, Javier; Mungall, Bruce

Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (Synflorix) in children.

Lecrenier, Nicolas; Marijam, Alen; Olbrecht, Jan; Soumahoro, Lamine; Nieto Guevara, Javier; Mungall, Bruce.

Affiliation

Lecrenier N; GSK Vaccines, GSK, Wavre, Belgium.
Marijam A; GSK Vaccines, GSK, Wavre, Belgium.
Olbrecht J; GSK Vaccines, GSK, Wavre, Belgium.
Soumahoro L; GSK Vaccines, GSK, Wavre, Belgium.
Nieto Guevara J; GSK Vaccines, GSK, Panama City, Panama.
Mungall B; GSK Vaccines, GSK, Wavre, Belgium.

Expert Rev Vaccines ; 19(3): 247-265, 2020 03.

Article de En | MEDLINE | ID: mdl-32195602

Sujet(s)
Mots clés

Children; PHiD-CV; effectiveness; efficacy; immunogenicity; impact; infants; pneumococcal conjugate vaccine; post-marketing surveillance

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à pneumocoques / Vaccination / Vaccins antipneumococciques Limites: Child, preschool / Humans / Infant Langue: En Journal: Expert Rev Vaccines Sujet du journal: ALERGIA E IMUNOLOGIA Année: 2020 Type de document: Article Pays d'affiliation: Belgique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google